The upcoming Xtalks webinar, scheduled for July 22, 2026, aims to bridge the gap between high-level oncology data and operational execution. The session features a panel of industry leaders, including Dannelle Palmer of Humaneva, Scott Schliebner and Dr. Julio A. Peguero of P1 Pratia Oncology, and Dr. Brandon Fletcher of Kapadi. They will dissect how emerging evidence—ranging from bispecific antibodies to genomic-informed care—necessitates a redesign of patient selection, safety oversight, and recruitment strategies.

Participants will examine the intersection of sponsor objectives and site-level realities. The discussion focuses on translating complex scientific advances into tangible patient benefits while maintaining data quality in an increasingly personalized therapeutic landscape. The event starts at 10am EDT and offers a collaborative look at what sponsors, CROs, and investigators must change to keep pace with rapid oncological innovation.